Vestal Point Capital, LP Ionis Pharmaceuticals Inc Transaction History
Vestal Point Capital, LP
- $2.21 Trillion
- Q3 2025
A detailed history of Vestal Point Capital, LP transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Vestal Point Capital, LP holds 1,075,000 shares of IONS stock, worth $76.9 Million. This represents 3.18% of its overall portfolio holdings.
Number of Shares
1,075,000
Previous 500,000
115.0%
Holding current value
$76.9 Million
Previous $19.8 Billion
255.99%
% of portfolio
3.18%
Previous 1.04%
Shares
3 transactions
Others Institutions Holding IONS
# of Institutions
507Shares Held
155MCall Options Held
2.69MPut Options Held
1.03M-
Vanguard Group Inc Valley Forge, PA16.5MShares$1.18 Billion0.02% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD13.2MShares$941 Million0.53% of portfolio
-
Capital World Investors Los Angeles, CA12.7MShares$910 Million0.12% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$738 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA6.59MShares$471 Million0.08% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $10.2B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...